ribociclib
novartis
['nct03701334', 'natalee', 'ribociclib', 'mbc']
ribociclib has already shown survival benefits in mbc. using it earlier for hr positive, her2-negative ebc with hormonal therapy where cancer that has not yet spread to lymph nodes, may improve survival by up to 25%. more time for patients #natalee trial (nct03701334) #asco23